(Q33864902)

29 July 2017

1 reference

title

Drug-mediated toxicity caused by genetic deficiency of UDP-glucuronosyltransferases (English)

1 reference

29 July 2017

Burchell B

1

1 reference

29 July 2017

Soars M

2

1 reference

29 July 2017

Monaghan G

3

1 reference

29 July 2017

Cassidy A

4

1 reference

29 July 2017

Smith D

5

1 reference

29 July 2017

Ethell B

6

1 reference

29 July 2017

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

112-113

1 reference

29 July 2017

333-340

1 reference

The UGT1A1*28 allele is relatively rare in a Japanese population

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Analysis of genes for bilirubin UDP-glucuronosyltransferase in Gilbert's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Paracetamol glucuronidation by recombinant rat and human phenol UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Human UDP-glucuronosyl transferases: chemical defence, jaundice and gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Genetic defects of the UDP-glucuronosyltransferase-1 (UGT1) gene that cause familial non-haemolytic unconjugated hyperbilirubinaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Decreased glucuronidation and increased bioactivation of acetaminophen in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

A universal radiochemical high-performance liquid chromatographic assay for the determination of UDP-glucuronosyltransferase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Unconjugated Bilirubin and an Increased Proportion of Bilirubin Monoconjugates in the Bile of Patients with Gilbert's Syndrome and Crigler-Najjar Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Pathogenesis of Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Expression of a human liver cDNA encoding a UDP-glucuronosyltransferase catalysing the glucuronidation of hyodeoxycholic acid in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Pharmacokinetic and pharmacodynamic evaluation of the topoisomerase inhibitor irinotecan in cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Disposition of lorazepam in Gilbert's syndrome: effects of fasting, feeding, and enterohepatic circulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

1 reference

7 January 2021

Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

The glucuronidation of exogenous and endogenous compounds by stably expressed rat and human UDP-glucuronosyltransferase 1.1

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Gilbert's syndrome is caused by a heterozygous missense mutation in the gene for bilirubin UDP-glucuronosyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Gilbert??s Syndrome and Drug Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Genetic variation in bilirubin UPD-glucuronosyltransferase gene promoter and Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

UGT1*1 genotyping in a Canadian Inuit population

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Interindividual variability in the glucuronidation of (S) oxazepam contrasted with that of (R) oxazepam.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Pathophysiology and therapy of irinotecan-induced delayed-onset diarrhea in patients with advanced colorectal cancer: a prospective assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

The genetic basis of Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism?

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Severe CPT-11 toxicity in patients with Gilbert's syndrome: two case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

1 reference

7 January 2021

Contribution of two missense mutations (G71R and Y486D) of the bilirubin UDP glycosyltransferase (UGT1A1) gene to phenotypes of Gilbert's syndrome and Crigler-Najjar syndrome type II

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

Interindividual and interethnic differences in the demethylation and glucuronidation of codeine

1 reference

https://api.crossref.org/works/10.1016%2FS0378-4274%2899%2900209-X

7 January 2021

10.1016/S0378-4274(99)00209-X

Identifiers

DOI

1 reference

29 July 2017

1 reference